Abstract:Background Long intergenic non-protein coding RNA 1140 (LINC01140), a long non-coding RNA, is highly expressed in various cancers; however, its biological functions in lung cancer (LC) progression and immune escape are still unclear. Methods Here, to elucidate LINC01140 function, 79 paired LC and paracancerous tissues were collected. LINC01140 expression levels were determined using fluorescence in situ hybridization and qPCR analysis. Cell counting kit-8 (CCK-8) assay and transwell assays were performed. The interaction between microRNAs (miRNAs) and LINC01140 was confirmed using an RNA immunoprecipitation assay. Cytokine-induced killer (CIK) cell phenotypes were analyzed by flow cytometry. Cytokine secretion levels were determined by ELISA. CIK cytotoxicity was assessed by measuring lactate dehydrogenase release. Besides, xenograft tumor mouse models were used to unveil the in vivo function of LINC01140. Results We found that LINC01140 was highly expressed in human LC tissues and cell lines. High LINC01140 levels were associated with poor survival in patients with LC. LINC01140 upregulation promoted the proliferation, migration, and invasion of LC cells through direct interaction with miR-33a-5p and miR-33b-5p, thereby contributing to c-Myc expression and also inhibited cisplatin-induced cell apoptosis. In subcutaneous tumor xenograft mice, LINC01140 knockdown markedly reduced tumor growth and lung metastasis. Additionally, LINC01140 directly repressed miR-377-3 p and miR-155-5 p expression levels, resulting in the upregulation of their common downstream target programmed death-ligand 1 (PD-L1), a crucial target in LC immunotherapy. Notably, we proved that LINC01140 knockdown, along with CIK administration, suppressed the growth of subcutaneous LC xenografts by decreasing PD-L1 expression in severe combined immunodeficient mice. Conclusions Taken together, LINC01140 overexpression protects c-Myc and PD-L1 mRNA from miRNA-mediated inhibition and contributes to the proliferation, migration, invasion, and immune escape of LC cells. These results provide a theoretical basis that LINC01140 is a promising target for LC treatment.

Downregulation of LINC01296 Suppresses Non-Small-cell Lung Cancer Via Targeting Mir-143-3p/atg2b.

LINC01207 Promotes the Progression of Non-Small Cell Lung Cancer Via Regulating ARHGAP11A by Sponging Mir-525-5p

Downregulated long intergenic non-coding RNA 00,174 represses malignant biological behaviors of lung cancer cells by regulating microRNA-584-3p/ribosomal protein S24 axis

Upregulation of Long Intergenic Noncoding RNA 00673 Promotes Tumor Proliferation Via LSD1 Interaction and Repression of NCALD in Non-Small-cell Lung Cancer.

LncRNA CCDC144NL-AS1 Serves As a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting Mir-490-3p

Upregulation of Long Intergenic Non-Coding RNA LINC00326 Inhibits Non-Small Cell Lung Carcinoma Progression by Blocking Wnt/β-catenin Pathway Through Modulating the Mir-657/Dickkopf WNT Signaling Pathway Inhibitor 2 Axis

Downregulation of LINC00665 Confers Decreased Cell Proliferation and Invasion Via the Mir-138-5p/e2f3 Signaling Pathway in NSCLC.

LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs

Long Noncoding RNA LINC01296 Induces Non-Small Cell Lung Cancer Growth and Progression Through Sponging Mir-5095

Long Non-Coding RNA LINC01224 Promotes Progression and Cisplatin Resistance in Non-Small Lung Cancer by Sponging Mir-2467.

LINC00472 suppresses non-small cell lung cancer progression via regulating miR-23a-3p/CCL22 axis

Dysregulated <i>LINC00961</i> Contributes to the Vitality and Migration of NSCLC Via miR-19a-3p/miR-19b-3p/miR-125b-5p

LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway

Long Non-coding RNA LINC01426 Contributes to the Malignant Behaviors of NSCLC Via Acting As a Sponge for Mir-143-3p

Long noncoding RNA LINC00961 inhibits cell invasion and metastasis in human non-small cell lung cancer.

The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer

Long Non‑coding RNA00887 Reduces the Invasion and Metastasis of Non‑small Cell Lung Cancer by Causing the Degradation of Mirnas.

Long Non-Coding Rna 00312 Regulated by Hoxa5 Inhibits Tumour Proliferation and Promotes Apoptosis in Non-Small Cell Lung Cancer

LincRNA00494 Suppresses Non-small Cell Lung Cancer Cell Proliferation by Regulating SRCIN1 Expression As a Cerna

LINC01783 facilitates cell proliferation, migration and invasion in non-small cell lung cancer by targeting miR-432-5p to activate the notch pathway

RETRACTED ARTICLE: the Lnc LINC00461/miR-30a-5p Facilitates Progression and Malignancy in Non-Small Cell Lung Cancer Via Regulating ZEB2